Drug Profile


Alternative Names: Piclamast; RP 73401; RPR 73401

Latest Information Update: 17 Dec 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aventis
  • Class Benzamides; Pyridines; Small molecules
  • Mechanism of Action Tumour necrosis factor inhibitors; Type 4 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Dermatitis; Rheumatoid arthritis
  • Discontinued Asthma

Most Recent Events

  • 17 Dec 2003 No development reported - Preclinical for Dermatitis in Germany (unspecified route)
  • 06 Nov 2000 Preclinical development for Dermatitis in Germany (Unknown route)
  • 06 Nov 2000 A preclinical study has been added to the Skin disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top